Imaging for personalized treatment of head and neck cancer
Official title: The EMINENCE Study - PET/MR Imaging of Head Neck Cancer
Run by Norwegian University of Science and Technology · NCT04612075 · Data updated 2026-11-12
This study is testing if using advanced imaging techniques can help personalize radiotherapy for people with head and neck cancer to improve their treatment results and reduce side effects.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 390 (estimated) |
| Sponsor | Norwegian University of Science and Technology Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 2 sites (Tromsø and 1 other locations) |
| Status | Recruiting |
| Started | January 12, 2021 |
| Main results expected | December 31, 2025 |
| Study ends | December 2028 |
| Registry record updated | April 14, 2026 |
| Trial ID | NCT04612075 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include patients with histologically confirmed locally advanced squamous cell carcinoma in the head and neck region who are scheduled for definitive radiotherapy.
✕Probably not a fit
Patients with general contraindications for MRI or serious comorbidities may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study focuses on improving radiotherapy for head and neck cancers by utilizing advanced imaging techniques, specifically PET and MRI. By capturing images before and during treatment, the study aims to quantify intratumoral characteristics such as oxygenation and metabolism, which can help tailor radiotherapy to individual patient needs. The goal is to establish a clinical workflow that enhances the precision of radiotherapy, potentially leading to better treatment outcomes and fewer side effects for patients. The study will also explore the integration of proton therapy as a future treatment option.
Why it matters
Potential benefit: If successful, this approach could lead to more personalized and effective radiotherapy for head and neck cancer patients, improving their outcomes and quality of life.
How similar studies have gone: Other studies utilizing advanced imaging techniques for personalized radiotherapy have shown promising results, indicating potential success for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * willing and able to give full written consent according to the protocol approved by the Regional Ethics Committee * histologically confirmed squamous cell carcinoma in the head neck region (pharynx, larynx, oral cavity or sinonasal area) * locally advanced disease without sign of dissemination (T3/T4 and/or N1-3, M0) on diagnostic imaging * scheduled for definitive radiotherapy with curative intent with or without concomitant chemotherapy * adequate renal function: Creatinine clearance ≥ 60 ml/minute * lymph node metastasis from cancer of unknown primary of the upper neck (i.e. level II-III) were PET/CT is negative outside the head-neck region can be considered for inclusion at the discretion of the study investigators. Exclusion Criteria: * general contraindications for MRI (pacemaker, aneurysm clips, any form of metal in the body, severe claustrophobia) * serious comorbidity (including previous or othe cancer) that in the opinion of the investigator would compromise the patient's ability to complete the study of interfere with the evaluation of the study objectives (e.g. poorly controlled diabetes mellitus) * histologically confirmed SCC of same or other origin within the last five years * patient wants to withdraw for any reason during the study
Where it's running
-
St Olavs Hospital, Department of Oncology
Trondheim, Norway Recruiting -
University Hospital of North Norway
Tromsø, Norway Not yet recruiting
Study contacts
- Study coordinator: Miriam Alsaker, phd
- Email: mirjam.alsaker@ntnu.no
- Phone: +47 73598709
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Longer antibiotic prophylaxis after head and neck cancer surgery
This trial tests whether giving antibiotics for 7 days after major mouth and throat cancer surgery reduces wound infections compared with the standard 24-hour course.
-
Tai Chi during radiotherapy for head and neck cancer fatigue
This trial tests whether a 12-week Yang-style Tai Chi program added to usual care can reduce cancer-related fatigue in adults with head and neck cancer undergoing radiotherapy.
-
Topical Boswellia 2% Cream to Prevent Radiation Dermatitis in Head and Neck Cancer
A topical 2% Boswellia serrata cream is tested to see if it can prevent skin irritation from radiation in people with head and neck cancer.
-
Methylscape test in body fluids for multi-cancer detection in Colombia
A simple blood, urine, or saliva test called Methylscape is being tested to see if it can detect multiple cancers and identify where the signal is coming from, using people with cancer and healthy volunteers in Colombia.
-
Foot reflexology and ta-VNS for symptom relief in head and neck cancer during CCRT
This trial tests whether foot reflexology, transcutaneous auricular vagus nerve stimulation, and auricular acupressure can reduce pain, dry mouth, fatigue, and other symptoms for head and neck cancer patients receiving cisplatin-based chemoradiotherapy.
-
Ozone gas plus biomimetic toothpaste and mouthwash to treat cancer therapy mouth sores
This trial will test whether adding a biomimetic toothpaste and mouthwash to ozone gas therapy helps adults with chemo- or radiotherapy-induced mouth sores heal faster and have less pain.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.